Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 AGA technical review on osteoporosis in hepatic disorders.

Literature DB >> 12949738

AGA technical review on osteoporosis in hepatic disorders.

William D Leslie¹, Charles N Bernstein, Meryl S Leboff.

Abstract

Entities: Disease

Mesh：

Substances：
Vitamin D

Year: 2003 PMID： 12949738 DOI： 10.1016/s0016-5085(03)01062-x

Source DB: PubMed Journal: Gastroenterology ISSN： 0016-5085 Impact factor: 22.682

Keyword Cloud
Cited

× No keyword cloud information.

65 in total

1. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.

Authors: Vincent Lo Re; Jessica Volk; Craig W Newcomb; Yu-Xiao Yang; Cristin P Freeman; Sean Hennessy; Jay R Kostman; Pablo Tebas; Mary B Leonard; A Russell Localio
Journal: Hepatology Date: 2012-10-14 Impact factor: 17.425

2. Effect of rapamycin on hepatic osteodystrophy in rats with portasystemic shunting.

Authors: Schalk W van der Merwe; Maria M Conradie; Robert Bond; Brenda J Olivier; Elongo Fritz; Martin Nieuwoudt; Rhena Delport; Tomas Slavik; Gert Engelbrecht; Del Kahn; Enid G Shephard; Maritha J Kotze; Nico P de Villiers; Stephen Hough
Journal: World J Gastroenterol Date: 2006-07-28 Impact factor: 5.742

3. Effect of liver dysfunction on circulating sclerostin.

Authors: Yumie Rhee; Won Jin Kim; Ki Jun Han; Sung Kil Lim; Se Hwa Kim
Journal: J Bone Miner Metab Date: 2013-10-15 Impact factor: 2.626

Review 4. Hepatic osteodystrophy.

Authors: Angelo Gatta; Alberto Verardo; Marco Di Pascoli; Sandro Giannini; Massimo Bolognesi
Journal: Clin Cases Miner Bone Metab Date: 2014-09

AGA technical review on osteoporosis in hepatic disorders.

1. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection.

2. Effect of rapamycin on hepatic osteodystrophy in rats with portasystemic shunting.

3. Effect of liver dysfunction on circulating sclerostin.

Review 4. Hepatic osteodystrophy.

5. Effects of total bilirubin on the prevalence of osteoporosis in postmenopausal women without potential liver disease.

Review 6. Bone health and vitamin D status in alcoholic liver disease.

7. Hepatic osteodystrophy is common in patients with noncholestatic liver disease.

8. Hepatic osteodystrophy: An important matter for consideration in chronic liver disease.

9. Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not men.

Review 10. Current understanding of osteoporosis associated with liver disease.